PodcastIntel
Sign in Get Started Free
Urology Times
Urology Times

Decipher may help identify ADT benefit in intermediate-risk prostate cancer

Oct 5, 2026 · 0:05:59
Listen to Episode
✨ AI Summary
  • Decipher classifier predicted metastasis risk in intermediate-risk prostate cancer.
  • Genomic classifier identified patients benefiting from short-term ADT.
  • Analysis of NRG/RTOG 0815 trial data informed findings.

Guests on This Episode

AJ
Angela Jia
successful doctoral candidate at the University of York · 1 podcast appearance
›

More from Urology Times

Urology Times
When surgery may be needed for prolonged ischemic priapism
Oct 12, 2026 · 0:02:34
Urology Times
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
Oct 12, 2026 · 0:03:53
Urology Times
How can urologists separate personalized medicine from marketing?
Oct 9, 2026 · 0:04:29
Urology Times
Why ctDNA serves as a rule-out in NeoBLAST's response assessment
Oct 8, 2026 · 0:06:56
View all episodes →

Get AI Summaries for Every New Episode

Subscribe to Urology Times and get AI summaries, guest tracking, and email digests delivered automatically.

Sign Up Free →